Apellis Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 27 07:40 ET
Apellis Pharmaceuticals | 8-K: Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 27 07:35 ET
Apellis Pharmaceuticals | 8-K: Current report
Jan 22 00:00 ET
Apellis Pharmaceuticals | 8-K: Current report
Jan 8 00:00 ET
Apellis Pharmaceuticals | 8-K: Current report
Dec 14, 2023 07:04 ET
Apellis Pharmaceuticals | 8-K: Current report
Dec 1, 2023 08:37 ET
Apellis Pharmaceuticals | 8-K: Current report
Nov 1, 2023 07:59 ET
Apellis Pharmaceuticals | 8-K: Current report
Oct 5, 2023 07:15 ET
Apellis Pharmaceuticals | 8-K: Current report
Aug 29, 2023 07:05 ET
Apellis Pharmaceuticals | 8-K: Current report
Aug 22, 2023 16:49 ET
Apellis Pharmaceuticals | 8-K: Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results
Jul 31, 2023 08:03 ET
Apellis Pharmaceuticals | 8-K: Current report
Jul 17, 2023 16:14 ET
Apellis Pharmaceuticals | 8-K: Current report
Jun 1, 2023 16:10 ET
Apellis Pharmaceuticals | DEFA14A: Others
Apr 21, 2023 09:03 ET
Apellis Pharmaceuticals | DEF 14A: Definitive proxy statements
Apr 21, 2023 09:00 ET
Apellis Pharmaceuticals | 8-K: Current report
Mar 15, 2023 16:37 ET
Apellis Pharmaceuticals | 8-K: Current report
Feb 24, 2023 09:27 ET
Apellis Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Feb 22, 2023 07:17 ET
Apellis Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 21, 2023 16:25 ET
Apellis Pharmaceuticals | 8-K: Current report
Jan 9, 2023 11:56 ET
No Data
No Data